Back

Oral GLP-1 RA – a step change in cardiology?

31 August 2019 (16:10 - 16:20)
Organised by:
Congress Presentation Part of: GLP-1 Receptor agonists – Pioneers of further cardiovascular risk reduction in diabetes? Diabetes and the Heart ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Lawrence Leiter

University of Toronto, Toronto (Canada)

5 More presentations in this session

Presentation thumbnail
Diabetes and cardiovascular risk – Ugly twins
Professor L. Leiter (Toronto, CA)
Slides
Presentation thumbnail
Incretins and glucose homeostasis
Doctor J. Meier (Bochum, DE)
Slides Video
Presentation thumbnail
GLP-1 and the cardiovascular system
Doctor M. Husain (Toronto, CA)
Slides Video
Presentation thumbnail
Pioneering oral GLP-1 RAs in cardiovascular risk management
Professor A. Consoli (Pescara, IT)
Slides
Presentation thumbnail
Panel discussion
Professor L. Leiter (Toronto, CA)
Video

Access the full session

Session thumbnail
GLP-1 Receptor agonists – Pioneers of further cardiovascular risk reduction in diabetes?

The Event

Event poster

ESC Congress 2019

31 August 2019 16:10 CET
You may be interested in
thumbnail
Webinar
Prevention of heart failure in diabetic patients at population level
thumbnail
Congress Session
Diabetes, obesity, and heart failure
thumbnail
Webinar
Diabetes and ACS - enhancing post-discharge outcomes after primary PCI

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources